- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Colon polyp.
Displaying page 1 of 2.
EudraCT Number: 2010-023643-15 | Sponsor Protocol Number: BUSCOPAN_PDR1 | Start Date*: 2011-01-18 | |||||||||||||||||||||
Sponsor Name:Deventer Hospital | |||||||||||||||||||||||
Full Title: The influence of hyoscine N-butylbromide on colonoscopic polyp detection ratio | |||||||||||||||||||||||
Medical condition: It is investigated whether the administration of Buscopan will improve the detection, removal and harvesting of colonic polyps during colonoscopy. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001084-27 | Sponsor Protocol Number: APAC | Start Date*: 2006-06-16 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALI GALLIERA | |||||||||||||
Full Title: Phase I/II study of prevention of Colorectal Cancer CRC with Allopurinol in High-Risk Subjects | |||||||||||||
Medical condition: CHEMOPREVENTION OF COLORECTAL CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005694-23 | Sponsor Protocol Number: CB-17-01/05 | Start Date*: 2011-12-20 | |||||||||||||||||||||
Sponsor Name:COSMO TECHNOLOGIES LTD | |||||||||||||||||||||||
Full Title: Polyp detection rate after single oral dose of methylene blue MMX(R) modified release tablets administered to subjects undergoing outpatients colonoscopy | |||||||||||||||||||||||
Medical condition: patients scheduled for the screening or surveillance colonoscopy and meeting the joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer and the Ameri... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001815-29 | Sponsor Protocol Number: MDL_2011_36557 | Start Date*: 2011-11-11 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: Chemopreventive effects of mesalazine in patients at high risk of recurrent (nonfamilial) colorectal adenomas | |||||||||||||
Medical condition: sporadic colorectal adenomas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001351-40 | Sponsor Protocol Number: MES-CT01 | Start Date*: 2012-05-02 | ||||||||||||||||
Sponsor Name:SOFAR SPA | ||||||||||||||||||
Full Title: ND | ||||||||||||||||||
Medical condition: NA | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-000131-51 | Sponsor Protocol Number: 1921 | Start Date*: 2019-03-07 | ||||||||||||||||
Sponsor Name:Zealand University Hospital | ||||||||||||||||||
Full Title: Preoperative endoscopic treatment with fosfomycin and metronidazole in patients with right-sided colon cancer and colon adenoma: a clinical proof-of-concept intervention study MEFO trial | ||||||||||||||||||
Medical condition: Colon cancer in track 1. Colon adenoma in track 2. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005275-16 | Sponsor Protocol Number: IEOS672/611 | Start Date*: 2012-11-12 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: Radio-guided minimally invasive resection of early colon cancer | |||||||||||||
Medical condition: colon cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002364-25 | Sponsor Protocol Number: NOR-01/2011(PDR) | Start Date*: 2011-10-31 | |||||||||||
Sponsor Name:Norgine Limited | |||||||||||||
Full Title: A multi-centre, randomised, investigator-blinded study comparing the polyp detection rate of two different types of bowel preparation: a 2-litre solution (MOVIPREP®) versus a hyperosmotic and stimu... | |||||||||||||
Medical condition: Patients with clinical symptoms or polyp history scheduled for either a diagnostic/surveillance colonoscopy or for a screening procedure in patients with a personal or familial risk of colon neopla... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005634-12 | Sponsor Protocol Number: EPA/POL/02 | Start Date*: 2006-06-12 |
Sponsor Name:S.L.A. Pharma (UK) Ltd | ||
Full Title: The effect of two dose levels of eicosapentaenoic acid (EPA) on apoptosis and cell proliferation in the colonic mucosa of patients with a history of colonic polyps. | ||
Medical condition: Sporadic colonic adenomata | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002185-78 | Sponsor Protocol Number: NER1006-02/2014 | Start Date*: 2014-10-10 | |||||||||||
Sponsor Name:Norgine Ltd | |||||||||||||
Full Title: A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) versus MOVIPREP® using a 2... | |||||||||||||
Medical condition: Bowel cleansing prior to any procedure that requires a clean bowel, e.g. colonoscopy, surgical, video capsule or radiological procedures. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) IT (Completed) ES (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002186-30 | Sponsor Protocol Number: NER1006-03/2014 | Start Date*: 2014-10-10 |
Sponsor Name:Norgine Ltd | ||
Full Title: A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) versus a Sodium Picosulfat... | ||
Medical condition: Bowel cleansing prior to any procedure that requires a clean bowel, e.g. colonoscopy, surgical, video capsule or radiological procedures. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) NL (Completed) ES (Completed) PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002836-18 | Sponsor Protocol Number: EPA/POL/03 | Start Date*: 2006-10-09 | |||||||||||
Sponsor Name:S.L.A. Pharma (UK) Ltd | |||||||||||||
Full Title: A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis Coli Patients Using the Purified Free Fatty Acid, Eicosapentaenoic Acid. | |||||||||||||
Medical condition: Familial adenomatous polyposis (FAP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003304-39 | Sponsor Protocol Number: 007 | Start Date*: 2019-01-23 | ||||||||||||||||
Sponsor Name:Morten Rasmussen | ||||||||||||||||||
Full Title: Efficacy of a novel 1l PEG plus ascorbate (Plenvu) bowel preparation vs. 2l PEG plus ascorbate (Moviprep), a randomized controlled multicenter trial | ||||||||||||||||||
Medical condition: Bowel preparation before colonoscopy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020943-10 | Sponsor Protocol Number: GA10/9312 | Start Date*: 2011-03-16 | |||||||||||
Sponsor Name:University of Leeds | |||||||||||||
Full Title: A randomised controlled trial of eicosapentaenoic acid (EPA) and/or aspirin for colorectal adenoma (or polyp) prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme... | |||||||||||||
Medical condition: colorectal adenoma (polyp) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002228-40 | Sponsor Protocol Number: A3191193 | Start Date*: 2006-08-28 |
Sponsor Name:PFIZER | ||
Full Title: A PHASE III PLACEBO-CONTROLLED TRIAL OF CELECOXIB IN GENOTYPE POSITIVE SUBJECTS WITH FAMILIAL ADENOMATOUS POLYPOSIS | ||
Medical condition: FAMILIAL ADENOMATOUS POLYPOSIS (FAP) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) SE (Completed) IT (Prematurely Ended) GB (Completed) CZ (Prematurely Ended) BE (Prematurely Ended) DE (Completed) HU (Prematurely Ended) SK (Completed) BG (Not Authorised) | ||
Trial results: View results |
EudraCT Number: 2012-002024-32 | Sponsor Protocol Number: Mesapol | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie | |||||||||||||
Full Title: Mesapol: The effect of mesalazine on molecular pathways of cell adhesion in patients with colon polyps | |||||||||||||
Medical condition: Colon polyps | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002809-34 | Sponsor Protocol Number: EPA-POL-04 | Start Date*: 2018-08-16 | |||||||||||
Sponsor Name:SLA Pharma (UK) Ltd | |||||||||||||
Full Title: Randomised, double-blind, placebo-controlled study of the, efficacy, safety and tolerability of EPA-FFA gastro-resistant capsules, in patients with familial adenomatous polyposis (FAP) | |||||||||||||
Medical condition: Familial Adenomatous Polyposis (FAP) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) NL (Completed) DE (Ongoing) IT (Prematurely Ended) DK (Completed) PL (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002562-12 | Sponsor Protocol Number: ENDOS2019 | Start Date*: 2019-09-09 |
Sponsor Name:HOSPITAL GENERAL DE CATALUNYA | ||
Full Title: PRAGMATIC, COMPARATIVE AND RANDOMIZED CLINICAL TRIAL OF THE NEW SOLUTION OF 1 LITER POLYETHYLENE GLYCOL VERSUS SODIUM PICOSULFATE WITH MAGNESIUM CITRATE IN THE EFFECTIVENESS OF SCREENING AND SURVE... | ||
Medical condition: Screening and surveillance colonoscopy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004384-75 | Sponsor Protocol Number: 37970 | Start Date*: 2012-09-10 | ||||||||||||||||
Sponsor Name: | ||||||||||||||||||
Full Title: Randomized controlled trial: Picoprep versus Moviprep for efficacy, safety and patient tolerability in colonoscopy bowel preparation. | ||||||||||||||||||
Medical condition: Patients who need a colonoscopy for screening, surveillance or diagnosis of a disease have to be prepared by bowel cleansing | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003770-85 | Sponsor Protocol Number: DKFZ-2019-007 | Start Date*: 2020-08-20 |
Sponsor Name:German Cancer Research Center (DKFZ) | ||
Full Title: Effect of low-dose acetylsalicylic acid on early detection of advanced colorectal neoplasms | ||
Medical condition: Screening for advanced colorectal neoplasms. Male individuals aged 40 to 79 years scheduled for screening colonscopy and no use of acetylsalicylic acid (or other drugs with an effect on the blood ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
